$355 Million is the total value of SECTOR GAMMA AS's 28 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Sell | MEDTRONIC PLC | $35,896,475 | +0.2% | 411,893 | -5.3% | 10.12% | +16.3% |
| PFE | Buy | PFIZER INC | $34,386,829 | +9.2% | 1,239,165 | +13.3% | 9.69% | +26.9% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $27,035,607 | +40.6% | 498,536 | +33.1% | 7.62% | +63.3% |
| CVS | Buy | CVS HEALTH CORP | $24,566,399 | +42.1% | 308,004 | +40.6% | 6.92% | +65.0% |
| CAH | Buy | CARDINAL HEALTH INC | $20,431,485 | +23.4% | 182,587 | +11.1% | 5.76% | +43.3% |
| GILD | Sell | GILEAD SCIENCES INC | $19,456,592 | -37.2% | 265,619 | -30.5% | 5.48% | -27.0% |
| ANTM | Buy | ELEVANCE HEALTH INC | $17,784,366 | +35.6% | 34,297 | +23.3% | 5.01% | +57.5% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $15,973,935 | -7.1% | 121,033 | -14.3% | 4.50% | +8.0% |
| INCY | Sell | INCYTE CORP | $15,091,068 | -39.7% | 264,895 | -33.6% | 4.25% | -30.0% |
| BAX | Sell | BAXTER INTL INC | $13,810,149 | +8.9% | 323,120 | -1.5% | 3.89% | +26.4% |
| BIIB | Sell | BIOGEN INC | $12,872,680 | -51.3% | 59,698 | -41.6% | 3.63% | -43.5% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $12,750,487 | – | 69,881 | +100.0% | 3.59% | – |
| BIO | Buy | BIO RAD LABS INCcl a | $11,642,676 | +52.7% | 33,662 | +42.6% | 3.28% | +77.4% |
| Sell | GE HEALTHCARE TECHNOLOGIES I | $11,194,021 | -41.5% | 123,133 | -50.3% | 3.16% | -32.1% | |
| BRKR | Sell | BRUKER CORP | $10,594,084 | +13.2% | 112,775 | -11.4% | 2.99% | +31.5% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $10,212,115 | -28.6% | 106,866 | -43.0% | 2.88% | -17.1% |
| THC | Sell | TENET HEALTHCARE CORP | $8,149,704 | -44.2% | 77,535 | -59.9% | 2.30% | -35.2% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $7,608,228 | +3.7% | 175,507 | +21.0% | 2.14% | +20.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $7,110,873 | -14.5% | 81,416 | -5.6% | 2.00% | -0.7% |
| ALKS | Buy | ALKERMES PLC | $6,830,275 | +23.1% | 252,319 | +26.2% | 1.92% | +43.0% |
| GMED | Sell | GLOBUS MED INCcl a | $5,652,637 | -54.7% | 105,381 | -55.0% | 1.59% | -47.4% |
| VTRS | New | VIATRIS INC | $4,986,825 | – | 417,657 | +100.0% | 1.41% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $4,806,413 | – | 164,378 | +100.0% | 1.36% | – |
| New | QIAGEN NV | $4,443,833 | – | 103,369 | +100.0% | 1.25% | – | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,122,279 | -32.9% | 27,583 | -14.1% | 1.16% | -22.0% |
| LNTH | Buy | LANTHEUS HLDGS INC | $3,302,454 | +1.8% | 53,060 | +1.4% | 0.93% | +18.3% |
| ILMN | Sell | ILLUMINA INC | $2,334,440 | -58.7% | 17,000 | -58.1% | 0.66% | -52.0% |
| CNC | Sell | CENTENE CORP DEL | $1,743,512 | -89.1% | 22,216 | -89.7% | 0.49% | -87.4% |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -148,538 | -100.0% | -0.36% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -39,876 | -100.0% | -1.06% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -102,490 | -100.0% | -1.19% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -188,111 | -100.0% | -1.43% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -190,539 | -100.0% | -2.01% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -50,686 | -100.0% | -2.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIO RAD LABS INC | 43 | Q2 2024 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 41 | Q2 2024 | 11.9% |
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BAXTER INTL INC | 37 | Q2 2024 | 12.7% |
| CARDINAL HEALTH INC | 37 | Q2 2024 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 33 | Q2 2024 | 7.6% |
| ELEVANCE HEALTH INC | 33 | Q2 2024 | 5.6% |
| GILEAD SCIENCES INC | 32 | Q2 2024 | 14.0% |
| TENET HEALTHCARE CORP | 31 | Q2 2024 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-09 |
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.